Product Details

Verceph Capsules meet Indian Pharmacopoeia (IP) standards for the treatment of bacterial infections. Specifically, each capsule delivers Cephalexin IP at 500mg. As a result, it offers reliable first-generation cephalosporin coverage for a range of common bacterial infections.

The capsules contain:

• Cephalexin IP (500mg) – A first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. Consequently, it exerts bactericidal activity against a broad range of susceptible gram-positive and select gram-negative organisms.

Physicians prescribe Verceph for the treatment of susceptible bacterial infections, including respiratory tract infections, skin and soft tissue infections, urinary tract infections, and bone infections. In addition, its established safety profile and oral dosing make it a reliable first-line option across a wide range of clinical settings. Because of this profile, Verceph suits general practice, paediatric, and hospital settings where dependable antibacterial therapy is needed.

Key Features:

• Overall, this IP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the oral capsule format supports easy, convenient dosing
• Furthermore, each capsule delivers precise, validated dosage accuracy at 500mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, blister packaging protects capsule integrity against light and moisture
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies